About Chiron Therapeutics
Pioneering the future of regenerative medicine through innovative stem cell technology
We Are On A Bold Mission
To deliver safe, scalable, and effective adult stem cell therapies for patients.
Safety First
Current stem cell methods risk patient safety, creating an urgent need for safer, non-transgenic and virus-free approach to produce scalable adult stem cells for therapy.
High-Yield Production
Our IP-licensed method generates large quantities of tissue-specific adult stem cells from somatic cells without transgenes or viruses.
Enhanced Safety
By eliminating genetic manipulation, our approach significantly reduces the risk of tumorigenesis and genetic instabilities.
Minimally Invasive
Our technology allows for the generation of therapeutic cells from easily accessible tissues like skin, reducing patient discomfort.
Our SIST Technology Process
The Suspension-Induced Stem Cell Transition (SIST) technology is our proprietary method for generating tissue-specific adult stem cells without genetic modification or viral vectors.
Our closed-loop process takes cells from collection to treatment with our revolutionary SIST reprogramming method.
Our History & Vision
At Chiron Therapeutics, we are reimagining what is possible in cell therapy. Inspired by the legendary healer Chiron, we harness the body's own regenerative power to tackle some of today's most urgent medical challenges.
Our mission is bold and focused: to deliver safe, scalable, and life-changing adult stem cell therapies. Backed by decades of expertise in stem cell biology and clinical translation, our founding team built Chiron around a breakthrough platform—the Suspension-Induced Stem Cell Transition (SIST) method. This patented technology enables unprecedented expansion of adult stem cells, unlocking their full clinical potential.
Unlike the complexity and risk of iPSC-based approaches, our adult stem cell platform offers a faster, safer, and more direct path to the clinic.
From orthopedic injuries to chronic diseases, we are committed to turning advanced science into real-world healing—bridging the gap between innovation and impact.
Our Promising Stem Cell Therapy Pipelines
Two cutting-edge autograft stem cell therapies in development. Backed by robust proof-of-concept data, our SIST technology demonstrates promising safer, scalable solutions for diseases like Orthopedic Disorders (cartilage regeneration) and Skin and Wound Healing (Burn injuries).
Advancing the Future of Regenerative Medicine
Our pipeline features two next-generation autologous stem cell therapies, powered by our proprietary SIST platform. Backed by strong proof-of-concept data, these therapies offer safer, scalable alternatives for high-need indications:
Orthopedic Disorders
Targeted cartilage regeneration for joint repair and mobility restoration
Skin & Wound Healing
Accelerated healing for burn injuries and chronic wounds
With a focus on real-world applicability and clinical readiness, Chiron is building a pipeline designed to move swiftly from lab to patient.